About Index Trending news
Analyze
Top 50 Pricing
AntriaBio

AntriaBio

Work at AntriaBio? Add yourself to this profile

AntriaBio

AntriaBio is developing proprietary products in sustained release injectable formulations including AB101, a once-a-week basal insulin. $ANTB

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Venture capital (Series A)
$4,350,000
Venture capital
$2,000,000
Employees

Team size

10+
Locations
$7,000,000 Venture capital
Xconomy

Colorado Roundup: AntriaBio Raises $7M, VSCO Buys Artifact Uprising | Xconomy